Article

Are You Blind to One Cause of Lupus Treatment Failure?

A steroid's "cosmetic" side effects mean more to your lupus patients than you may think. A new study finds that what you see as fairly unimportant could have troubling implications.

Hale ED, Radvanski DC, Hassett AL. The man-in-the-moon face: a qualitative study of body image, self-image and medication use in systemic lupus erythematosus.Rheumatology (Oxford). 2014 Dec 29; pii: keu448. [Epub ahead of print]

Compared to other issues, the "moon face" and weight gain that accompany steroids may not loom large for a rheumatologist treating systemic lupus erythematosus (SLE). But minimizing the negative impact of SLE on patient's body image as a mere "cosmetic" problem often leads to delays in diagnosis or "creative" treatment nonadherence, this small study shows.

Patients who feel their doctors make light of it may leave the practice.

In the study, 15 SLE patients took part in hour-long interviews. All but one were women aged from 22 to 67. Disease duration ranged from 3 to 20 years.

One-third reported that they waited a while after the onset of less-dramatic symptoms to obtain a definitive SLE diagnosis, as doctors minimized symptoms or attributed them to "lifestyle factors such as weight gain.”

The researchers note that “it was not uncommon for participants to have tried a period of non-adherence to medication, often driven by side effects, depression, feeling temporarily better or a desire to exert control.”

Patients said they were often too overwhelmed by their diagnosis to question treatment choices. Also, although they tried to appear optimistic many became so discouraged by these problems that they stopped socializing. Two marriages broke up.

SLE patients need more psychosocial help coping with the effect of SLE on their lives, these researchers conclude. Patients felt their doctors need more training in how to discuss an overwhelming diagnosis such as SLE, including medication side effects and personal issues such as appearance.

 

 

 

 

 

 

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.